The nonstructural protein NS3 of the hepatitis C virus (HCV)harbors a serine protease domainthat is responsible for most of the processing events of thenonstructural region of the polyprotein. Itsinhibition is presently regar
ded as a promising strategy for copingwith the disease caused by HCV. Inthis work, we show that the NS3 protease un
dergoes inhibition by theN-terminal cleavage products ofsubstrate pepti
des corresponding to the NS4A-NS4B, NS4B-NS5A, andNS5A-NS5B cleavage sites,whereas no inhibition is observed with a cleavage product of theintramolecular NS3-NS4A junction.The
Ki values of the hexamer inhibitoryproducts [
Ki(NS4A) = 0.6
![](/images/entities/mgr.gif)
M,
Ki(NS5A) = 1.4
![](/images/entities/mgr.gif)
M, and
Ki(NS4B) = 180
![](/images/entities/mgr.gif)
M] are lower than the
Kmvalues of the respective substrate pepti
des[
Km(NS4A-NS4B)= 10
![](/images/entities/mgr.gif)
M,
Km(NS5A-NS5B) = 3.8
![](/images/entities/mgr.gif)
M,and
Km(NS4B-NS5A) > 1000
![](/images/entities/mgr.gif)
M].Mutagenesis experimentshave i
dentified Lys136 as an important
determinant for product binding.The phenomenon of productinhibition can be exploited to optimize pepti
de inhibitors of NS3protease activity that may be useful indrug
development.